Tops & Flops Stocks
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | 7.260% | 7.258% | 17.699% | -8.904% | 10.833% | 18.750% | -33.633% |
Grindeks AS | 7.330% | - | - | - | - | - | - |
Infinity Pharmaceuticals Inc. | 7.360% | - | - | - | - | - | - |
BioInvent International AB | 7.380% | 12.245% | 51.469% | 3.774% | 50.915% | -53.258% | -5.534% |
Allergy Therapeutics PLC | 7.580% | 16.393% | 20.339% | -25.263% | 65.116% | -85.685% | - |
Heron Therapeutics Inc. | 7.770% | 8.193% | 7.019% | 152.821% | 88.408% | -74.053% | - |
Cellmid Ltd | 7.940% | - | - | - | - | - | - |
Saniona AB | 8.490% | 10.621% | -2.450% | -74.160% | -59.155% | -92.767% | - |
Osmotica Pharmaceuticals PLC | 8.780% | - | - | - | - | - | - |
Cara Therapeutics Inc. | 8.890% | 7.399% | 7.321% | -82.131% | 5.696% | -93.263% | -95.736% |
Scryb Inc. | 9.090% | 2.500% | -2.381% | -73.582% | 31.410% | -89.351% | - |
Alimera Sciences | 9.190% | - | - | - | - | - | - |
PTC Therapeutics Inc. | 9.220% | 9.220% | 31.624% | -37.903% | 22.222% | 0.000% | -11.520% |
Onxeo S.A. | 9.410% | 7.000% | -8.703% | -60.370% | -29.373% | -83.982% | -86.951% |
Abeona Therapeutics Inc. | 9.740% | 5.825% | -40.680% | 57.174% | -7.431% | -83.882% | - |
MacroGenics Inc. | 9.830% | -65.532% | -70.076% | -16.107% | -47.800% | -80.376% | - |
Esperion Therapeutis.Inc. | 9.870% | 20.670% | 31.947% | 51.529% | -17.108% | -87.518% | -94.596% |
Vaxart Inc. | 10.170% | 40.297% | 12.055% | -18.347% | 82.991% | -82.656% | - |
Jaguar Health Inc. | 10.730% | -6.671% | 56.361% | -57.236% | 74.172% | -99.886% | - |
Stoke Therapeutics Inc | 11.860% | 17.117% | 10.169% | - | - | - | - |
Ziopharm Oncology | 11.930% | - | - | - | - | - | - |
Novavax Inc. | 11.950% | 215.303% | 252.825% | 88.307% | 196.484% | -87.797% | 129.946% |
Bionomics Ltd. | 12.120% | - | - | - | - | - | - |
Biomark Diagnostics Inc. | 13.790% | -5.714% | 3.125% | 0.610% | 0.610% | -26.991% | 251.812% |
Cytocom Inc. | 13.970% | - | - | - | - | - | - |